68 related articles for article (PubMed ID: 17785332)
21. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
22. Intraepithelial lymphocytes in celiac disease.
Järvinen TT; Kaukinen K; Laurila K; Kyrönpalo S; Rasmussen M; Mäki M; Korhonen H; Reunala T; Collin P
Am J Gastroenterol; 2003 Jun; 98(6):1332-7. PubMed ID: 12818278
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of the lymphocyte activation antigen CD30 in active celiac disease.
Periolo N; Guillén L; Bernardo D; Niveloni SI; Hwang HJ; Garrote JA; Bai JC; Arranz E; Cherñavsky AC
Autoimmunity; 2010 Jun; 43(4):288-98. PubMed ID: 20166880
[TBL] [Abstract][Full Text] [Related]
24. Duodenal cytotoxic lymphocytes in cow's milk protein sensitive enteropathy and coeliac disease.
Augustin MT; Kokkonen J; Karttunen TJ
Scand J Gastroenterol; 2005 Dec; 40(12):1398-406. PubMed ID: 16293554
[TBL] [Abstract][Full Text] [Related]
25. Galectin-10, eosinophils, and celiac disease.
De Re V; Simula MP; Cannizzaro R; Pavan A; De Zorzi MA; Toffoli G; Canzonieri V
Ann N Y Acad Sci; 2009 Sep; 1173():357-64. PubMed ID: 19758173
[TBL] [Abstract][Full Text] [Related]
26. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
27. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical and T-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease.
Arguelles-Grande C; Brar P; Green PH; Bhagat G
J Clin Gastroenterol; 2013 Aug; 47(7):593-601. PubMed ID: 23470642
[TBL] [Abstract][Full Text] [Related]
29. T cell receptor heterogeneity in gamma delta T cell clones from intestinal biopsies of patients with celiac disease.
De Libero G; Rocci MP; Casorati G; Giachino C; Oderda G; Tavassoli K; Migone N
Eur J Immunol; 1993 Feb; 23(2):499-504. PubMed ID: 8436183
[TBL] [Abstract][Full Text] [Related]
30. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.
Di Sabatino A; Ciccocioppo R; Cupelli F; Cinque B; Millimaggi D; Clarkson MM; Paulli M; Cifone MG; Corazza GR
Gut; 2006 Apr; 55(4):469-77. PubMed ID: 16105889
[TBL] [Abstract][Full Text] [Related]
31. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
32. Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation.
Olaussen RW; Karlsson MR; Lundin KE; Jahnsen J; Brandtzaeg P; Farstad IN
Gastroenterology; 2007 Jun; 132(7):2371-82. PubMed ID: 17570212
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
34. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
35. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
36. Immune modulation by non-hodgkin lymphoma in a patient with two primary intestinal T-cell lymphomas and long-standing celiac disease.
Mühr-Wilkenshoff F; Friedrich M; Foss HD; Hummel M; Zeitz M; Daum S
Digestion; 2010; 81(4):231-4. PubMed ID: 20110707
[TBL] [Abstract][Full Text] [Related]
37. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
38. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
[TBL] [Abstract][Full Text] [Related]
39. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
40. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
